United States · FDA National Drug Code directory
TROGARZO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62064-122_c04624be-0e28-4902-954c-730ccdbfd162
- Product NDC
- 62064-122
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ibalizumab
- Labeler
- Theratechnologies Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20180420
- Source listing expiry
- 20271231
Source-listed ingredients
- IBALIZUMAB — 150 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 VIAL, SINGLE-USE in 1 CARTON (62064-122-02) / 1.33 mL in 1 VIAL, SINGLE-USE (62064-122-01) · 62064-122-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →